+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America, Middle East & Africa Cardiac Biomarkers Testing Market (2019-2025)

  • ID: 4801481
  • Report
  • Region: Africa, East Africa, Latin America, Middle East
  • 103 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Johnson and Johnson
  • Quidel Corporation
  • Siemens AG
  • MORE
The Latin America, Middle East and Africa Cardiac Biomarkers Testing Market is expected to witness market growth of 12.4% CAGR during the forecast period (2019–2025).

Conventional laboratory tests use cardiac biomarkers to examine the cardiac anomalies that result in cardiac arrest and ACS. Since these laboratories focus on providing reliable and accurate results, the vendors are increasingly concentrating on developing cardiac biomarkers for laboratory services. Hospitals make use of cardiac biomarkers to rapidly detect myocardial necrosis and to increase the survival rate of patients. Hospitals and specialty clinics use cardiac biomarkers for imaging procedures for cardiology to detect the level of anomalies which may lead to heart failure. Specialty clinics offer specialized health packages at reduced costs for imaging services for patients suffering from diabetes accompanied by cardiac abnormalities.

Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Scope of the Study

Market Segmentation:

By Type
  • Creatine Kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP and NT-proBNP)
  • Ischemia Modified Albumin
  • Others
By Application
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
By Location of Testing
  • Point of Care Testing
  • Laboratory Testing
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Johnson and Johnson
  • Quidel Corporation
  • Siemens AG
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cardiac Biomarkers Testing Market, by Type
1.4.2 LAMEA Cardiac Biomarkers Testing Market, by Application
1.4.3 LAMEA Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 LAMEA Cardiac Biomarkers Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint

Chapter 3. LAMEA Cardiac Biomarkers Testing Market by Type
3.1.1 LAMEA Creatine Kinase (CK-MB) Market by Country
3.1.2 LAMEA Troponins Market by Country
3.1.3 LAMEA Myoglobin Market by Country
3.1.4 LAMEA Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 LAMEA Ischemia Modified Albumin Market by Country
3.1.6 LAMEA Others Market by Country

Chapter 4. LAMEA Cardiac Biomarkers Testing Market by Application
4.1.1 LAMEA Myocardial Infarction Market by Country
4.1.2 LAMEA Congestive Heart Failure Market by Country
4.1.3 LAMEA Acute Coronary Syndrome Market by Country
4.1.4 LAMEA Atherosclerosis Market by Country
4.1.5 LAMEA Others Market by Country

Chapter 5. LAMEA Cardiac Biomarkers Testing Market by Location of Testing
5.1.1 LAMEA Point of Care Testing Market by Country
5.1.2 LAMEA Laboratory Testing Market by Country

Chapter 6. LAMEA Cardiac Biomarkers Testing Market by Country
6.1 Brazil Cardiac Biomarkers Testing Market
6.1.1 Brazil Cardiac Biomarkers Testing Market by Type
6.1.2 Brazil Cardiac Biomarkers Testing Market by Application
6.1.3 Brazil Cardiac Biomarkers Testing Market by Location of Testing
6.2 Argentina Cardiac Biomarkers Testing Market
6.2.1 Argentina Cardiac Biomarkers Testing Market by Type
6.2.2 Argentina Cardiac Biomarkers Testing Market by Application
6.2.3 Argentina Cardiac Biomarkers Testing Market by Location of Testing
6.3 UAE Cardiac Biomarkers Testing Market
6.3.1 UAE Cardiac Biomarkers Testing Market by Type
6.3.2 UAE Cardiac Biomarkers Testing Market by Application
6.3.3 UAE Cardiac Biomarkers Testing Market by Location of Testing
6.4 Saudi Arabia Cardiac Biomarkers Testing Market
6.4.1 Saudi Arabia Cardiac Biomarkers Testing Market by Type
6.4.2 Saudi Arabia Cardiac Biomarkers Testing Market by Application
6.4.3 Saudi Arabia Cardiac Biomarkers Testing Market by Location of Testing
6.5 South Africa Cardiac Biomarkers Testing Market
6.5.1 South Africa Cardiac Biomarkers Testing Market by Type
6.5.2 South Africa Cardiac Biomarkers Testing Market by Application
6.5.3 South Africa Cardiac Biomarkers Testing Market by Location of Testing
6.6 Nigeria Cardiac Biomarkers Testing Market
6.6.1 Nigeria Cardiac Biomarkers Testing Market by Type
6.6.2 Nigeria Cardiac Biomarkers Testing Market by Application
6.6.3 Nigeria Cardiac Biomarkers Testing Market by Location of Testing
6.7 Rest of LAMEA Cardiac Biomarkers Testing Market
6.7.1 Rest of LAMEA Cardiac Biomarkers Testing Market by Type
6.7.2 Rest of LAMEA Cardiac Biomarkers Testing Market by Application
6.7.3 Rest of LAMEA Cardiac Biomarkers Testing Market by Location of Testing

Chapter 7. Company Profiles
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
Note: Product cover images may vary from those shown
Adroll
adroll